APOPTOSIS INDUCTION IN HUMAN BREAST-CANCER MRK-NU-1 CELLS BY A POLYAMINE SYNTHESIS INHIBITOR, METHYLGLYOXAL HIS (CYCLOPENTYLAMIDINOHYDRAZONE) (MGBCP)
Citation
H. Kaneko et al., APOPTOSIS INDUCTION IN HUMAN BREAST-CANCER MRK-NU-1 CELLS BY A POLYAMINE SYNTHESIS INHIBITOR, METHYLGLYOXAL HIS (CYCLOPENTYLAMIDINOHYDRAZONE) (MGBCP), Anticancer research, 18(2A), 1998, pp. 891-896
Categorie Soggetti
Oncology
SICI code
0250-7005(1998)18:2A<891:AIIHBM>2.0.ZU;2-P
Abstract
We have investigated the antiproliferative effects of a polyamine synt
hesis inhibitor; methylglyoxal bis(cyclopentylamidinohydrazone) (MCBCP
), on human breast cancer MRK-nu-1 cells. MGBCP inhibited tumor growth
of MRK-nu-1 cells in a dose-dependent manner as the polyamine content
s in the cells decreased. Moreover, morphological changes indicating b
lebbing and chromatin condensation were observed in the MGBCP-treated
cells, and hypodiploid subpopulations containing apoptotic cells were
clearly detected in the profile of flow cytometric analysis. The numbe
r of characteristic oligonucleosome-sized fragments also increased as
the concentration of MGBCP increased The apoptotic effects of MGBCP we
re partially prevented by the addition of exogenous spermine. The resu
lts presented here suggest that, in addition to reducing the growth ra
te, MGBCP can induce apoptotic cell death in MRK-nu-1 human breast can
cer-cells by the reduction of intracellular concentrations of polyamin
es.